Supernus Pharmaceuticals, Inc.
USD46.85
+0.05 (+0.11%)
CEO
Jack A. Khattar
IPO Date
2012-05-01
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
Country
US
Open
$46.64
Prev. Close
$46.80
Day Low
$46.16
Day High
$47.08
52W Low
$31.35
52W High
$59.68
Market Cap
$2.72B
Volume
0.36M
| 27.0 |
| 31 Dec 2023 | FY | 86.2% | 0.2% | 0.1% | 0.1% | 0.05 | 1.70 | 1199.3 |
| 31 Dec 2022 | FY | 86.9% | 9.1% | 6.9% | 3.6% | 0.50 | 1.07 | 31.5 |
| 31 Dec 2021 | FY | 87.1% | 9.2% | 6.5% | 3.2% | 0.52 | 1.91 | 29.0 |
| 31 Dec 2020 | FY | 89.9% | 24.4% | 17.0% | 8.4% | 0.56 | 2.57 | 10.4 |
| 31 Dec 2019 | FY | 95.8% | 28.8% | 19.0% | 9.7% | 0.64 | 2.94 | 11.0 |
| 31 Dec 2018 | FY | 96.2% | 27.1% | 24.5% | 11.4% | 0.73 | 3.06 | 15.6 |
| 31 Dec 2017 | FY | 95.0% | 19.0% | 21.4% | 13.5% | 0.10 | 1.86 | 35.3 |
| 31 Dec 2016 | FY | 94.4% | 42.4% | 47.6% | 29.5% | 0.02 | 1.88 | 13.7 |
| -173.6 |
| 30 Sept 2025 | Q3 | 90.1% | -23.5% | -4.3% | -3.2% | 0.03 | 1.80 | -14.9 |
| 30 Jun 2025 | Q2 | 89.8% | 13.6% | 2.1% | 1.6% | 0.03 | 2.58 | 19.6 |
| 31 Mar 2025 | Q1 | 89.5% | -7.9% | -1.1% | -0.9% | 0.03 | 2.44 | -38.7 |
| 31 Dec 2024 | Q4 | 85.0% | 8.8% | 1.5% | 1.1% | 0.03 | 2.35 | 32.7 |
| 30 Sept 2024 | Q3 | 90.0% | 21.9% | 3.8% | 2.9% | 0.04 | 2.20 | 11.2 |
| 30 Jun 2024 | Q2 | 89.4% | 11.8% | 2.1% | 1.5% | 0.04 | 1.91 | 18.3 |
| 31 Mar 2024 | Q1 | 88.6% | 0.1% | 0.0% | 0.0% | 0.05 | 1.73 | 3703.5 |
| 31 Dec 2023 | Q4 | 88.1% | 0.7% | 0.1% | 0.1% | 0.05 | 1.70 | 336.0 |